Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acid

British Journal of Pharmacology

Volumn 122, Issue 3, 1997, Pages 584-590

  Green, M A ^a   Halliwell, R F ^b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

5 HT3; GABA(A) receptors; Glycine receptor; Ligand gated channels; Nicotinic cholinoceptors; NSAIDs; P2(X) receptors; Quinolones

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE TRIPHOSPHATE DERIVATIVE; BEMESETRON; BICUCULLINE; CIPROFLOXACIN; DIAZEPAM; FELBINAC; HEXAMETHONIUM; ION CHANNEL; NICOTINIC RECEPTOR; PENTOBARBITAL; PICROTOXIN; PURINE P2X RECEPTOR; SEROTONIN; SEROTONIN 3 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; DRUG POTENTIATION; MALE; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; VAGUS NERVE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BICUCULLINE; CIPROFLOXACIN; DIMETHYLPHENYLPIPERAZINIUM IODIDE; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GANGLIONIC STIMULANTS; MALE; OPTIC NERVE; PHENYLACETATES; PICROTOXIN; RATS; RATS, WISTAR; RECEPTORS, CHOLINERGIC; RECEPTORS, GABA-A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; SEROTONIN ANTAGONISTS; VAGUS NERVE;

EID: 0030929177     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701411     Document Type: Article

References (37)

1. AKAHANE, K., SEKIGUCHI, M., UNE, T. & OSADA, Y. (1989). Structure-epileptogenicity relationship of quinolones with special reference to their interaction with γ-aminobutyric acid receptor sites. Antimicrob. Agents Chemother., 33, 1704-1708.
2. AKAHANE, K., KIMURA, Y., TSUTOMI, Y. & HAYAKAWA, I. (1994). Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits γ-aminobutyric acid receptor sites. Antimicrob. Agents Chemother., 38, 2323-2329.
3. A receptors in dissociated hippocampal cells of the rat. J. Neurophysiol., 66, 497-504.
4. ANASTASIO, G.D., MENSCERY, D. & LITTLE, J.M. Jr. (1988). Norfloxacin and seizures. Ann. Intern. Med., 109, 169-170.
5. CHRIST, W. (1990). Central nervous system toxicity of quinolones: human and animal findings. J. Antimicrob. Chemother., 26 (Suppl. B), 219-225.
6. DODD, P.R., DAVIES, L.P., WATSON, W.E.J., NIELSEN, B., DYER, J.A., WONG, L.S. & JOHNSTON, G.A.R. (1989). Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA & adenosine systems in mammalian CNS. Pharmacol. Toxicol., 64, 404-411.
7. DOMAGALA, J.M. (1994). Structure-activity and structure-side-effect relationship for the quinolone antimicrobials. J. Antimicrob. Chemother., 33, 685-706.
8. FILLASTRE, J.P., LEROY, A., BORSA-LEBAS, F., ETIENNE, I., GY, C. & HUMBERT, G. (1993). Does a nonsteroidal anti-inflammatory drug modify the pharmacokinetics of pefloxacin and ofloxacin? Drugs, 45 (Suppl. 3), 295-296.
9. GIARDINA, W.J. (1991). Assessment of temafloxacin neurotoxicity in rodents. Am. J. Med., 91 (Suppl. 6A), 42S-44S.
10. GREEN, M.A., MARKHAM, A. & HALLIWELL, R.F. (1995). An electrophysiological study of the selectivity of action of ciprofloxacin and biphenylacetic acid on the rat isolated vagus nerve. Br. J. Pharmacol., 116, 336P.
11. HALLIWELL, R.F., DAVEY, P.G. & LAMBERT, J.J. (1991). The effects of quinolones and NSAIDs upon GABA-evoked currents recorded from dorsal root ganglion neurones. J. Antimicrob. Chemother., 27, 209-218.
12. A receptors by 4-quinolones. J. Antimicrob. Chemother., 31, 457-462.
13. A and ionotropic glutamate receptors. Neuropharmacology, 34, 1615-1624.
14. HOOPER, D.C. & WOLFSON, J.S. (1989). Adverse effects of quinolone antimicrobial agents. In Quinolone Antimicrobial Agents. ed. Wolfson, J.S. & Hooper, D.C. Washington D.C.: American Society for Microbiology.
15. HORI, S., SHIMADA, J., SAITO, A., MIYAHARA, T., KURIOKA, S. & MATSUDA, M. (1987). A study on enhanced epileptogenicity on new quinolones in the presence of antiinflammatory drugs. In Abstr. of the 27th. Intersci. Confer. on Antimicrob. Agents & Chetnother. New York. 30, p101. Washington, D.C.: American Society for Microbiology.
16. A receptor. Neuropharmacology, 35, 1271-1277.
17. IRELAND, S.J. & TYRES, M.B. (1987). Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br. J. Pharmacol., 90, 229-238.
18. A receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds. Neuropharmacology, 35, 1263-1269.
19. JANKNEGT, R. (1990). Drug interactions with quinolones. J. Antimicrob. Chemother., 26(Suppl. D), 7-29.
20. LIETMAN, P.S. (1995). Fluoroquinolone toxicities: An update. Drugs, 49(Suppl. 2), 156-163.
21. MARSH, S. (1989). Methods in Experimental Physiology and Pharmacology. Biological Measurement Techniques VI. Extracellular Recording from Rat Sympathetic Ganglia and Whole Nerve Bundles. D-7806 March-Hugstetten: Biomesstechnik-Verlag March GambH.
22. MATSUMOTO, R.R. (1989). GABA receptors: are cellular differences reflected in function? Brain Res. Rev., 14, 203-225.
23. MOTOMURA, M., KATAOKA, Y., TAKEO, G., SHIBAYAMA, K. OHISHI, K., NAKAMURA, T., NIWA, M., TSUJIHATA, M. & NAGATAKI, S. (1991). Hippocampus and frontal cortex are the potential mediatory sites for convulsions induced by new quinolones and non-steroidal anti-inflammatory drugs. Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 223-227.
24. A-receptor but do not always induce convulsion. In Abstracts of the 3rd International Symposium on New Quinolones, 450. P563. Vancouver, Canada.
25. SEGEV, S., REHEVI, M. & RUBENSTEIN, E. (1988). Quinolones, theophylline and diclofenac interactions with γ-amino butyric acid receptor. Antimicrobial Agents Chemother., 32, 1624-1626.
26. SHIRASAKI, T., HARATA, N., NAKAYE, T. & AKAIKE, N. (1991). Quinolones do not interact with NMDA receptors in dissociated rat hippocampal neurons. Brain Res., 562, 344-346.
27. A receptor subtypes. Pharmacol. Rev., 47, 181-234.
28. SIMMONDS, M.A. (1983). Depolarizing responses to glycine, β-alanine and muscimol in isolated optic nerve and cuneate nucleus. Br. J. Pharmacol., 79, 799-806.
29. SIMPSON, K.J. & BRODIE, M.J. (1985). Convulsions related to enoxacin. Lancet, ii 161.
30. 35S]t-butylbicyclophosphorothionate binding. Mol. Pharmacol., 43, 795-800.
31. STAHLMAN, R. (1990). Safety profile of the quinolones. J. Antimicrob. Chemother., 26 (Suppl D), 31-44.
32. TREZISE, D.J., KENNEDY, I. & HUMPHREY, P.P.A. (1994). The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by α,β-methylene adenosine 5′-triphosphate. Br. J. Pharmacol., 112, 282-288.
33. TSUJI, A., SATO, H., KUME, Y., TAMAI, K., OKEZAKI, E., NAGATA, O. & KATO, H. (1988). Inhibitory effects of quinolone antibacterial agents on γ-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob. Agents Chemother., 32, 190-194.
34. TSUTOMI, Y., MATSUBAYASHI, K. & AKAHANE, K. (1994). Quantitation of receptor inhibition required for quinolone-induced convulsions in mice. J. Antimicrob. Chemother., 34, 737-746.
35. UPTON, N. (1994). Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings. Trends Pharmacol. Sci., 15, 456-463.
36. A responses by a new class of quinolones and non-steroidal anti-inflammatories in dissociated frog sensory neurones. Br. J. Pharmacol., 105, 13-28.
37. YAMAMOTO, K., NAITOH, Y., INOUE, Y., YOSHIMURA, K., MORIKAWA, K., NAGATA, O., HASHIMOTO, S., YAMADA, T. & KUBO, S. (1988). Seizure discharges induced by the combination of new quinolonecarboxylic acid antimicrobial drugs and non-steroidal antiinflammatory drugs. Chemotherapy (Tokyo), 36 (Suppl. 2), 300-304.